The setup: a market trying to “grow into” its price
Lambes Invest’s core framing for U.S. equities starts with a simple observation: the S&P 500 has been leaning more on earnings than on ever-rising valuation multiples. That distinction matters because it changes how investors should read both good news and bad news—especially in a cycle where the Federal Reserve has already begun easing.
The late-cycle question for 2026 isn’t whether the market can move (it can), but what kind of fuel will dominate: faster profits, a re-rating of valuations, or a rotation that redistributes returns across sectors and sizes.
Rates and liquidity: why the Fed’s pivot matters more than one number
In Lambes Invest’s playbook, the Fed’s direction is the macro “gravity” under risk assets. At its December 2025 meeting, the FOMC cut the federal funds target range by 25 bps to 3.50%–3.75%, while emphasizing data dependence and noting elevated uncertainty.
That matters for U.S. stocks in three practical ways:
- Discount-rate pressure eases: long-duration equities (especially growth) become less rate-sensitive on the margin.
- Credit conditions can thaw: if funding costs stabilize, buybacks, capex, and M&A become more feasible.
- The “surprise function” changes: when policy is shifting toward accommodation, markets often react more to inflation re-acceleration than to growth deceleration.
In other words, the next shock may be less about recession fear and more about whether inflation progress stalls.
Earnings: the case for broader participation (not just mega-caps)
Lambes Invest’s earnings lens focuses on breadth, not just headline growth. FactSet’s bottom-up view expects S&P 500 CY 2026 earnings growth of ~15% (above the 10-year average cited by FactSet), and importantly suggests growth is not exclusively a “Magnificent 7” story: the “other 493” are projected to grow earnings as well.
This is the constructive interpretation of the tape: if profits broaden out, markets can advance even if valuations stop expanding. Schwab makes a similar point—describing a period where “the E has been doing the heavy lifting,” with less contribution from multiple expansion.
What Lambes Invest would watch inside earnings season
- Revision momentum (up/down estimate changes), not just beats
- Margin resilience (labor, input costs, and pricing power)
- Capex guidance (especially AI/data center, industrial automation, grid/power, and semis supply chain)
Valuation: high, but not a timing tool—think “shock sensitivity”
Lambes Invest typically treats valuation as a risk amplifier, not a calendar. FactSet places the forward 12-month P/E around the low-20s (above its longer-term averages, per the same report).
Schwab’s research adds a useful nuance: historically, the relationship between forward P/E and next-year returns is weak—so “expensive” doesn’t automatically mean “imminent decline,” but it can mean the market is more vulnerable to surprises.
On top of that, concentration remains a live issue. State Street highlights ongoing investor concerns around index concentration and valuations, noting how much weight sits in the largest names and how that can shape index behavior.
Translation into positioning risk: when a few stocks dominate index movement, headline indices can look stable while the median stock behaves very differently.
Macro backdrop: steady growth is helpful, but fragmentation is the wildcard
For U.S. equities, the “soft landing” narrative works best when global growth is steady and disinflation continues. The IMF’s October 2025 World Economic Outlook projects global growth moderating into 2026 and flags risks tied to uncertainty, protectionism, and fragmentation.
Lambes Invest’s takeaway: even if domestic fundamentals look fine, policy-driven volatility (trade rules, tariffs, industrial policy, supply chains) can reprice sectors quickly—especially cyclicals and globally exposed mega-caps.
Three scenarios Lambes Invest would run (and how the market might behave)
1) Base case: “earnings carry the index”
- Inflation trends down slowly; Fed eases gradually.
- Earnings growth broadens beyond the biggest tech names.
- Market returns skew toward stock selection and sector balance rather than a straight-line index melt-up.
2) Upside: “re-rating + breadth”
- Disinflation is cleaner than expected; financial conditions loosen.
- Multiples expand modestly and earnings remain firm.
- Small/mid caps and cyclicals participate more meaningfully.
(Strategists have argued that accommodative policy plus strong EPS can support valuation expansion, even from elevated levels.)
3) Downside: “shock sensitivity bites”
- Inflation re-accelerates or geopolitics/trade policy jolts supply chains.
- Rates back up; multiples compress; leadership narrows.
- High-concentration indices become more volatile because the same few names carry both the upside and the downside.
The 2026 “dashboard”: indicators that tend to matter most
Lambes Invest would likely keep a tight weekly/monthly checklist:
- Earnings revisions breadth (how many sectors are seeing estimate upgrades)
- Forward P/E + real rates (valuation pressure is usually a rate story, not a feelings story)
- Fed communication (cuts are bullish until inflation says otherwise)
- Policy/trade headlines (fragmentation risk is not theoretical)
- Concentration metrics (how dependent index returns are on the top cohort)
Bottom line: a “quality growth + breadth” year—if earnings stay real
Lambes Invest’s overall message would be: the U.S. stock market’s next leg is most sustainable when it’s earned—via profits that broaden across sectors—rather than granted by another round of indiscriminate multiple expansion. FactSet’s 2026 earnings expectations support the plausibility of that path, while the Fed’s easing posture is a tailwind as long as inflation doesn’t reassert control.
For investors and readers, the practical stance is less about predicting a single index level and more about tracking whether earnings breadth + policy direction remain aligned—because that alignment is what turns a good market into a durable one.